Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Current Assets (2021 - 2025)

Medicinova (MNOV) has disclosed Current Assets for 7 consecutive years, with $31.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets changed N/A to $31.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.0 million, a N/A change, with the full-year FY2025 number at $31.0 million, changed N/A from a year prior.
  • Current Assets was $31.0 million for Q4 2025 at Medicinova, down from $32.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $81.5 million in Q1 2021 to a low of $31.0 million in Q4 2025.
  • A 5-year average of $54.6 million and a median of $53.1 million in 2022 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: plummeted 30.21% in 2022, then decreased 0.29% in 2023.
  • Medicinova's Current Assets stood at $72.0 million in 2021, then dropped by 26.19% to $53.1 million in 2022, then dropped by 3.72% to $51.2 million in 2023, then decreased by 15.45% to $43.3 million in 2024, then fell by 28.37% to $31.0 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Current Assets are $31.0 million (Q4 2025), $32.9 million (Q3 2025), and $35.1 million (Q2 2025).